This 1-hour, on-demand session from the 2024 ASAM State of the Art Course covers most recent updates on emerging issues and advances in addiction medicine from the perspective of three major federal agencies: NIAAA, SAMHSA, and NIDA.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course examines new research on AUD treatment, including spironolactone, psychedelics, GLP-1, and technology-assisted approaches.

This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 1-hour, 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring disorders, such as HIV, hepatitis, infectious diseases, and stress and trauma.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This one-hour, on-demand, journal article-based activity presents a scoping review on the efficacy of GLP-1 agonists in the treatment of patients with substance use disorder. While there is interest in exploring the use of GLP-1 agonists in the treatment of SUD, evidence for safety and efficacy of GLP-1 agonists in humans is limited. The results of this scoping review are mixed, and the authors call for further research to determine the efficacy of GLP-1 agonists in treating SUD.

This one-hour, on-demand, journal article-based activity presents an evaluation of the World Health Organization (WHO) risk drinking level reductions and explores correlations with alcohol use disorder (AUD) diagnosis and criteria as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5e).

This 50-minute, on-demand session from the ASAM 2024 Review Course covers the screening for and identification of heavy drinking or alcohol use disorder while also discussing key methods of treatment and prevention.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the nuanced realm of prescribing medications for alcohol use disorder (MAUD) for individuals with liver disease.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the preclinical evidence in favor of repurposing GLP-1 receptor agonists as possible addiction pharmacotherapies.